Bardhan K D
District General Hospital, Rotherham, UK.
Postgrad Med J. 1988;64 Suppl 1:40-6.
Most patients with duodenal ulcer relapse but in individuals the events is unpredictable and complications are rare. Two methods of long term treatment have been developed: daily maintenance treatment to prevent relapse; and intermittent treatment, in which individual symptomatic relapses are treated with a short healing course. Pooling the results of three studies on intermittent treatment where cimetidine was used, the number of relapses in one year and the proportion of patients who relapsed were: no relapse, 26%; 1 relapse, 33%; 2 relapses, 24%; greater than or equal to 3 relapses, 17%. Thus, 83% of patients on average have less than or equal to 2 attacks per year, which can be rapidly controlled with a short course of treatment. In comparative trials, relapse on maintenance treatment is much less than on intermittent treatment, as would be expected, but the clinical advantage of the former is relatively small and obtained at a much higher cost in drugs. However, in practice, the two treatments are complementary, not competitive, and patients in whom maintenance treatment (or surgery) is necessary would not be considered for intermittent treatment. Most work on intermittent treatment has been done with histamine H2 receptor antagonists. Theoretically, better results might be achieved by increasing the healing rate with omeprazole or more effectively, by reducing the spontaneous relapse rate by healing with colloidal bismuth. Intermittent treatment is contraindicated in the one-third who are either 'high-risk' patients or those who have aggressive ulcer disease. It is suitable for the two-thirds who meet all the following criteria: age <60 years; no associated serious illness; no previous haemorrhage or perforation; not on regular treatment with non-steroidal anti-inflammatory drugs; symptoms develop gradually (se that treatment can be started before pain worsens); less than or equal 2 relapses per year; ulcer is non-refractory. It is essential to establish an accurate diagnosis before starting therapy. Treatment is given for a month and repeated when typical symptoms recur. Repeat endoscopy is not needed except in special circumstances. For the majority of patients, intermittent treatment is an effective, simple and economical way of providing long term treatment.
大多数十二指肠溃疡患者会复发,但具体到个体,复发情况难以预测,且并发症罕见。目前已开发出两种长期治疗方法:每日维持治疗以预防复发;间歇治疗,即针对个体症状性复发采用短期愈合疗程进行治疗。汇总三项使用西咪替丁进行间歇治疗的研究结果,一年中的复发次数及复发患者比例如下:无复发,26%;复发1次,33%;复发2次,24%;复发≥3次,17%。因此,平均83%的患者每年发作≤2次,可通过短期疗程迅速控制。在对比试验中,维持治疗的复发率远低于间歇治疗,这在意料之中,但前者的临床优势相对较小,且药物成本要高得多。然而,在实际应用中,这两种治疗方法是互补的,而非相互竞争,需要维持治疗(或手术)的患者不会考虑采用间歇治疗。大多数关于间歇治疗的研究是使用组胺H2受体拮抗剂进行的。从理论上讲,使用奥美拉唑提高愈合率,或更有效地使用胶体铋愈合以降低自发复发率,可能会取得更好的效果。三分之一的“高危”患者或患有侵袭性溃疡病的患者禁忌采用间歇治疗。它适用于符合以下所有标准的三分之二患者:年龄<60岁;无相关严重疾病;既往无出血或穿孔;未规律服用非甾体抗炎药;症状逐渐出现(以便在疼痛加重前开始治疗);每年复发≤2次;溃疡非难治性。开始治疗前必须准确诊断。治疗为期一个月,典型症状复发时重复治疗。特殊情况除外,一般无需重复内镜检查。对于大多数患者来说,间歇治疗是一种有效、简单且经济的长期治疗方式。